Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Anemia, Sickle Cell (Phase 2)
Brain Neoplasms (Phase 1)
Breast Neoplasms (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Esophageal Neoplasms (Phase 1/Phase 2)
Head and Neck Neoplasms (Phase 2)
Healthy Volunteers (Phase 1)
Leukemia, Myeloid, Acute (Phase 1)
Lung Neoplasms (Phase 2)
Lymphoma, B-Cell (Early Phase 1)
Lymphoma, Non-Hodgkin (Early Phase 1)
Lymphoma, T-Cell (Early Phase 1)
Melanoma (Phase 1)
Mesothelioma, Malignant (Phase 1/Phase 2)
Myelodysplastic Syndromes (Phase 1)
Neoplasm Metastasis (Phase 1)
Neoplasms (Phase 1)
Neoplasms, Germ Cell and Embryonal (Phase 1)
Pancreatic Neoplasms (Early Phase 1)
Sarcoma (Phase 1)
Urinary Bladder Neoplasms (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue